EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹1,469 Cr | ₹1,230 Cr | ₹1,181 Cr | ₹1,330 Cr | ₹1,232 Cr |
What is the latest Operating Profit of EMCURE PHARMACEUTICALS ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹1,469 Cr |
| Mar2024 | ₹1,230 Cr |
| Mar2023 | ₹1,181 Cr |
| Mar2022 | ₹1,330 Cr |
| Mar2021 | ₹1,232 Cr |
How is Operating Profit of EMCURE PHARMACEUTICALS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,469 Cr | 19.45 | |
| Mar2024 | ₹1,230 Cr | 4.11 | |
| Mar2023 | ₹1,181 Cr | -11.18 | |
| Mar2022 | ₹1,330 Cr | 7.95 | |
| Mar2021 | ₹1,232 Cr | - | |
Compare Operating Profit of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹35,632.3 Cr | -6.4% | 1% | 35% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹450,211.0 Cr | -3% | -4.1% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹228,303.0 Cr | 0.6% | 17.5% | 41.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.7% | -0.6% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,672.0 Cr | -2% | -0.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,533.5 Cr | -1.5% | -3.5% | -2.2% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -6.4% |
1% |
35% |
| SENSEX | -1.2% |
-1.2% |
-3.3% |
You may also like the below Video Courses